These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Haemodynamic effects of sulphinpyrazone on exercise responses in normal subjects. Forfar JC; Russell DC; Oliver MF Lancet; 1980 Oct; 2(8197):718-20. PubMed ID: 6106828 [TBL] [Abstract][Full Text] [Related]
6. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity. Siitonen L J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250 [TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension. Tuomilehto J; Nissinen A Eur J Clin Pharmacol; 1979; 16(6):369-74. PubMed ID: 393518 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension. Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934 [TBL] [Abstract][Full Text] [Related]
9. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study. Obel AO J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894 [TBL] [Abstract][Full Text] [Related]
10. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol. Franciosa JA; Johnson SM; Tobian LJ Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041 [No Abstract] [Full Text] [Related]
11. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. J Hypertens; 1985 Aug; 3(4):379-92. PubMed ID: 2864374 [TBL] [Abstract][Full Text] [Related]
12. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension. Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962 [TBL] [Abstract][Full Text] [Related]
13. Trial of combination of guanethidine and oxprenolol in hypertension. Pearson RM; Bending MR; Bulpitt CJ; George CF; Hole DR; Williams FM; Breckenridge AM Br Med J; 1976 Apr; 1(6015):933-6. PubMed ID: 773486 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. Wilcox RG; Hampton JR Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103 [TBL] [Abstract][Full Text] [Related]
15. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial. Gruppillo P; Tomasi AM; Masoni A; Finzi C G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694 [No Abstract] [Full Text] [Related]
16. A double-blind study of oxprenolol once and twice daily in hypertensive patients. Glazer N; Friedman B; Gerlings E; Gross S; Lowney C; Solomon R Clin Cardiol; 1983 Aug; 6(8):378-83. PubMed ID: 6352119 [TBL] [Abstract][Full Text] [Related]
17. Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical trial. Materson BJ; Friedman BA; Hla KM; Neidorf BS; Gray JM; Glazer N; Gross S Drug Intell Clin Pharm; 1983 Jan; 17(1):51-4. PubMed ID: 6337801 [TBL] [Abstract][Full Text] [Related]
18. Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients. Schlesinger Z; Ravid M; Meshulam R Cardiology; 1983; 70(4):199-205. PubMed ID: 6357438 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of oxprenolol and propranolol. Materson BJ; Michael UF; Oster JR; Perez-Stable EC Clin Pharmacol Ther; 1976 Aug; 20(2):142-51. PubMed ID: 780037 [TBL] [Abstract][Full Text] [Related]
20. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects. Costa FV; Borghi C; Ambrosioni E Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]